Published in Drug Week, March 26th, 2004
With the new dosing option, women suffering from PMDD can take Paxil CR once-daily during the 2-week period prior to the onset of their menstrual cycle rather than throughout the month. Paxil CR, the first and only controlled-release selective serotonin-reuptake inhibitor indicated for intermittent treatment of PMDD, is also indicated for the continuous treatment of PMDD, depression, social...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.